Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.

Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, Aoyagi S, Kinoshita H, Kuwano M.

Cancer Res. 2006 Jun 15;66(12):6233-42.

2.

The molecular genetics of pancreatic ductal carcinoma.

Sohn TA.

Minerva Chir. 2002 Oct;57(5):561-74. Review.

PMID:
12370658
3.
4.

Invasion and metastasis in pancreatic cancer.

Keleg S, Büchler P, Ludwig R, Büchler MW, Friess H.

Mol Cancer. 2003 Jan 22;2:14. Review.

5.

Bone marrow-derived proangiogenic cells in pancreatic cancer.

Mizukami Y.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:23-6. doi: 10.1111/j.1440-1746.2011.07012.x. Review.

PMID:
22320912
6.

[Biological aspects of pancreatic cancer].

Tonel E, Carbone A, Scirelli T, Bellone G, Emanuelli G.

Minerva Med. 2005 Apr;96(2):87-94. Review. Italian.

PMID:
16172578
7.

Pancreatic cancer: the role of pancreatic stellate cells in tumor progression.

Dunér S, Lopatko Lindman J, Ansari D, Gundewar C, Andersson R.

Pancreatology. 2010;10(6):673-81. doi: 10.1159/000320711. Epub 2011 Jan 18. Review.

8.

Transcriptional anti-angiogenesis therapy of human pancreatic cancer.

Xie K, Wei D, Huang S.

Cytokine Growth Factor Rev. 2006 Jun;17(3):147-56. Epub 2006 Mar 3. Review.

PMID:
16516532
9.

Anti-angiogenesis therapy in pancreatic carcinoma.

Saif MW.

JOP. 2006 Mar 9;7(2):163-73. Review.

10.

N-myc downstream regulated 1 gene and its place in the cellular machinery.

Kitowska A, Pawełczyk T.

Acta Biochim Pol. 2010;57(1):15-21. Epub 2010 Mar 19. Review.

11.

[Precursors to pancreatic cancer].

Søreide K, Immervoll H, Molven A.

Tidsskr Nor Laegeforen. 2006 Mar 23;126(7):905-8. Review. Norwegian.

12.

VAV1: a new target in pancreatic cancer?

Denicola G, Tuveson DA.

Cancer Biol Ther. 2005 May;4(5):509-11. Epub 2005 May 2. Review.

PMID:
15970675
13.

The molecular and cellular biology of pancreatic cancer.

Perugini RA, McDade TP, Vittimberga FJ Jr, Callery MP.

Crit Rev Eukaryot Gene Expr. 1998;8(3-4):377-93. Review.

PMID:
9807701
14.
15.

Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.

Rak J, Klement P, Yu J.

Vnitr Lek. 2006 Mar;52 Suppl 1:135-8. Review.

PMID:
16637463
16.

Molecular prognostic markers in pancreatic cancer.

Ghaneh P, Kawesha A, Evans JD, Neoptolemos JP.

J Hepatobiliary Pancreat Surg. 2002;9(1):1-11. Review.

PMID:
12021893
17.

Role of maspin in tumor metastasis and angiogenesis.

Schaefer JS, Zhang M.

Curr Mol Med. 2003 Nov;3(7):653-8. Review.

PMID:
14601639
18.

Molecular mechanisms of pancreatic carcinogenesis.

Furukawa T, Sunamura M, Horii A.

Cancer Sci. 2006 Jan;97(1):1-7. Review.

19.

Pancreatic cancer--new aspects of molecular biology research.

Kleeff J, Friess H, Berberat PO, Martignoni ME, Z'graggen K, Büchler MW.

Swiss Surg. 2000;6(5):231-4. Review.

PMID:
11077487
20.

Modeling pancreatic cancer in animals to address specific hypotheses.

Grippo PJ, Sandgren EP.

Methods Mol Med. 2005;103:217-43. Review.

PMID:
15542910

Supplemental Content

Support Center